Information For Authors
Interested in submitting to this journal? We recommend that you review the About the Journal page for the journal's section policies, as well as the Author Guidelines. Authors need to register with the journal prior to submitting or, if already registered, can simply log in and begin the five-step process.
Submission Preparation Checklist
As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
- The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
- The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
- Where available, URLs for the references have been provided.
- The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
- The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.
- Authors undertaking
- Conflict of Interest
Statements and opinions expressed in the articles and communications herein, including reader responses published in the Letters and Brief Communications section, are those of the author(s) and not necessarily those of the editors, the publisher, or LMRJ and the editors, the publisher, and LMRJ disclaim any responsibility or liability for such materials. The editors, the publisher, and LMRJ do not guarantee, warrant, or endorse any product or service advertised in this publication, nor do they guarantee any claim made by the manufacturer of such product or service.
Submission of a manuscript to Liaquat Medical Research Journal (LMRJ) implies the authors of the paper understand and fully accept the policies of the journal as detailed in these Instructions to Authors. Please read these instructions carefully and follow them strictly to ensure that the review and publication of your paper is as efficient and rapid as possible. The editors reserve the right to return manuscripts that are not in accordance with these instructions.
All manuscripts submitted for possible publication, including text, tables, graphics, and supplementary materials, should be submitted online via the journal's online submission system at: www.lumhs.edu.pk Original source files are preferred (not PDF files). The author should specify a category designation for the manuscript (Original Article, Review, Case Report, etc.) and choose a set of classifications from the prescribed list available online.
Authors may send queries concerning the submission process, manuscript status, or Journal procedures to the Editorial Office (firstname.lastname@example.org). Once the submission files are uploaded, the system automatically generates an electronic (PDF) proof, which is then used for reviewing. All correspondence, including the Editor's decision and any requests for revisions, will be by e-mail.
This journal operates a double blind review process. All contributions will be initially assessed by the manuscript editor for suitability for the journal once passed through Turnitin software. Papers deemed suitable are then typically sent to a minimum of two independent experts/ reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. The suggestions and objections of the reviewers after blinding are communicated to authors and only when reviewers are satisfy with the response of the authors than only the manuscript are accepted for publication.
Copyright to all articles and supplementary tables, illustrations, or other information published in Liaquat Medical Research Journal will be held by authors.
Conflicts of Interest
Authors of research articles should disclose at the time of revision any financial arrangement they may have with a company whose product is pertinent to the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision, but if the article is accepted for publication, a disclosure statement will appear with the article. Because the essence of reviews and editorials is selection and interpretation of the literature, the Journal expects that authors of such articles will not have any significant financial interest in a company (or its competitor) that makes a product discussed in the article.
The author should submit the manuscript typed in MS Word. Manuscripts should be written in English in British or American style/format (same style should be followed throughout the whole text), in past tense and third person form of address. Sentences should not start with a number or figure. Any illustrations or photographs should also be sent in duplicate. Components of manuscript should be in the following sequence: a title page (containing names of authors, their postal and Email addresses, fax and phone numbers, including mobile phone number of the corresponding author), abstract, key words, text, references, tables (each table, complete with title and footnotes) and legends for illustrations and photographs. Each component should begin on a new page. The manuscript should be typed in double spacing as a single column on A4 (8-1/2" x 11" or 21.5 cm x 28.0 cm), white bond paper with one inch (2.5 cm) margin on one side.
Material for publication
The material submitted for publication may be in the form of an Original research (Randomized controlled trial - RCT, Meta-analysis of RCT, Quasi-experimental study, Case Control study, Cohort study, Observational study with statistical support etc.), a Review Article, Commentary, a Case Report, Recent Advances, New techniques, Debates, Adverse Drug Reports, Current Practices, Clinical Practice Article, Short Article, KAP (Knowledge, Attitudes, Practices) study, An Audit Report, Evidence Based Report, Short Communication or a Letter to the Editor. Ideas and Innovations can be reported as changes made by the authors to an existing technique or development of a new technique or instrument. A mere description of a technique without any practical experience or innovation will be considered as an update and not an original article. Any study ending four years prior to date of submission is judged by Editorial Board for its suitability as many changes take place over the period of time, subject to area of the study.
Original articles should normally report original research of relevance to clinical medicine. The original paper should be of about 2000-2500 words excluding abstract and references. It should contain a structured abstract of about 250 words. Three to 10 keywords should be given for an original article as per MeSH (Medical Subject Headings). There should be no more than three tables or illustrations. The data should be supported with 20 to 25 references, which should include local as well as international references. Most of the references should be from last five years from the date of submission.
Clinical Practice Article is a category under which all simple observational case series are entertained. The length of such article should be around 1500 – 1600 words with 15 – 20 references. The rest of the format should be that of an original article. KAP studies, Audit reports, Current Practices, Survey reports and Short Articles are also written on the format of Clinical Practice Article. Evidence based reports must have at least 10 cases and word count of 1000 – 1200 words with 10 – 12 references and not more than 2 tables or illustrations. It should contain a non-structured abstract of about 150 words. Short communications should be of about 1000 words, having a non-structured abstract of about 150 words with one table or illustration and not more than five references. Clinical case reports must be of academic and educational value and provide relevance of the disease being reported as unusual. Brief or negative research findings may appear in this section.
The word count of case report should be 1200-1500 words with a minimum of 3 key words. It should have a non-structured abstract of about 100 – 150 words (case specific) with maximum of 10 references.
Review article should consist of critical overview/analysis of some relatively narrow topic providing background and the recent development with the reference of original literature. It should incorporate author’s original work on the same subject. The length of the review article should be of 2500 to 3000 words with minimum of 40 and maximum of 60 references. It should have non-structured abstract of 150 words with minimum 3 key words. An author can write a review article only if he/she has written a minimum of three original research articles and some case reports on the same topic.
Letters should normally not exceed 400 words, with not more than 5 references and be signed by all the authors-maximum 3 are allowed. Preference is given to those that take up points made in contributions published recently in the journal. Letters may be published with a response from the author of the article being discussed. Discussions beyond the initial letter and response will not be entertained for publication. Letters to the editor may be sent for peer review if they report a scientific data. Editorials are written by invitation.
3 to 10 key words should be given for all the category of manuscripts under the abstracts as per MeSH [Medical Subject Headings].
Manuscripts must conform to acceptable English usage. Standard abbreviations should be used consistently throughout the article. Abbreviations should be spelled out the first time they appear in
the text and followed in parentheses by the abbreviation.
Begin numbering with the title page as page 1, the structured abstract page as page 2, and continue throughout the references, figure legends, and tables. Place page numbers in the upper right corner of each page.
The title page should be typed double-spaced and include the title, authors' full names, highest earned academic degrees, institutional affiliations and location, and a short, abbreviated title of up to 40 characters or fewer. Designate one author (provide address, business telephone, fax numbers and e-mail address) to receive correspondence
Each article must include a structured abstract of no more than 250 words. Use the following headings for sections of the abstract: Objectives, Design, Setting, Methods, Results, Discussion and Conclusion. The abstract may not contain data not presented in the manuscript. The use of appropriate subheadings throughout the body of the text (Introduction, Methods, Results, and Discussion sections) is required for manuscripts. Following format should be adopted for Original Articles. Meanwhile, for a case report, a brief abstract about case, introduction about subject, case report, discussion and references parts should be given.
It should contain brief review of the topic with strictly relevant references & historical background. At the end, objectives and the rationale for the study should be mentioned.
In this section, mention design, place and duration of the study. It should clearly state inclusion and exclusion criteria of the subjects. The methods and the apparatus used should be identified (with manufacturer’s name and address in the parenthesis), and procedures described in sufficient detail to allow other workers to reproduce the results. Well established methods should be cited with references. Statistical tools used for analysis of results should also be mentioned in methods section with enough detail to enable the readers or researchers to verify the reported findings.
Important findings must be narrated in the text, tables and illustrations in logical sequence in numerical as well as in percentages. Repetitions should be avoided. Only important observations should be emphasized in precise manner.
It should emphasize the new and important aspects, implications and any limitations of the study. In this section, findings should be compared with already existing literature.
These should be specific to the goals of the study & authors own interpretation of the data. These should not be linked to other studies. Claiming priority or alluding to work that has not completed, must be avoided.
If author(s) want to present appropriate recommendations or suggestions, these may be included after conclusion section.
Persons who have contributed intellectually or technically to the paper but whose contributions do not justify authorship may be named and their function or contribution described. For example, “scientific advisor”, “critical review of study proposal“, “data collection” or “participation in clinical trial”. Such persons must have permitted to be named.
Vancouver style: It is a numbered referencing style commonly used in medicine and science, and consists of:
- Citations to someone else's work in the text, indicated by the use of a number.
- A sequentially numbered reference list at the end of the document providing full details of the corresponding in-text reference.
It follows rules established by the International Committee of Medical Journal Editors, now maintained by the U.S. National Library of Medicine. It is also known as Uniform Requirements for Manuscripts submitted to Biomedical Journals.
This guide is modeled on Citing Medicine: The NLM Style Guide for Authors, Editors, and Publishers (2nd edition). You may wish to consult this source directly for additional information or examples.
Reference list: General notes
- References are listed in numerical order, and in the same order in which they are cited in text. The reference list appears at the end of the paper.
- Begin your reference list on a new page and title it 'References'.
- The reference list should include all and only those references you have cited in the text. (However, do not include unpublished items such as correspondence.)
- Use Arabic numerals (1, 2, 3, 4, 5, 6, 7, 8, 9).
- Abbreviate journal titles in the style used in the NLM Catalog.
- Check the reference details against the actual source - you are indicating that you have read a source when you cite it.
- Be consistent with your referencing style across the document.
Example of a reference list
- O'Campo P, Dunn JR, editors. Rethinking social epidemiology: towards a science of change. Dordrecht: Springer; 2012. 348 p.
- Schiraldi GR. Post-traumatic stress disorder sourcebook: a guide to healing, recovery, and growth [Internet]. New York: McGraw-Hill; 2000 [cited 2006 Nov 6]. 446 p. Available from: http://books.mcgraw-hill.com/getbook.php?isbn=0071393722&template=#toc DOI:10.1036/0737302658
- Halpen-Felsher BL, Morrell HE. Preventing and reducing tobacco use. In: Berlan ED, Bravender T, editors. Adolescent medicine today: a guide to caring for the adolescent patient [Internet]. Singapore: World Scientific Publishing Co.; 2012 [cited 2012 Nov 3]. Chapter 18. Available from: http://www.worldscientific.com/doi/pdf/10.1142/9789814324496_0018
- Stockhausen L, Turale S. An explorative study of Australian nursing scholars and contemporary scholarship. J NursScholarsh [Internet]. 2011 Mar [cited 2013 Feb 19];43(1):89-96. Available from: http://search.proquest.com.ezproxy.lib.monash.edu.au/docview/858241255?accountid=12528
- Kanneganti P, Harris JD, Brophy RH, Carey JL, Lattermann C, Flanigan DC. The effect of smoking on ligament and cartilage surgery in the knee: a systematic review. Am J Sports Med [Internet]. 2012 Dec [cited 2013 Feb 19];40(12):2872-8. Available from:
- http://ajs.sagepub.com/content/40/12/2872 DOI: 10.1177/0363546512458223
- Subbarao M. Tough cases in carotid stenting [DVD]. Woodbury (CT): Cine-Med, Inc.; 2003. 1 DVD: sound, color, 4 3/4 in.
- Stem cells in the brain [television broadcast]. Catalyst. Sydney: ABC; 2009 Jun 25.
Referencing your own appendices in your own text:
- Your appendix does not need to be referenced. It is enough to signpost it the body of your work, for example: (See Appendix A).
- If you created your own appendix, and you've cited references, then number the references within the appendix consecutively in sequence with your written text and include them in your reference list.
Referencing appendices not written by you:
- If the appendix was not written by you then place the numbered citation, in sequence with the rest of the text, at the end of the appendix and include the full reference in your reference list.
Tables and illustrations
Legends to illustrations should be typed on the same sheet. Tables should be simple, and should supplement rather than duplicate information in the text; tables repeating information will be omitted. Each table should have a title and be typed in double space without horizontal and vertical lines on an 8-1/2" x 11" (21.5 x 28.0 centimeters) paper. Tables should be numbered consecutively with Roman numerals in the order they are mentioned in the text. Page number should be in the upper right corner. If abbreviations are used, they should be explained in footnotes. When Graphs, scatter grams, or histograms are submitted, the numerical data on which they are based should be supplied. All graphs should be made with MS Excel and other Windows/Macintosh compatible software such as SAS and be sent as a separate Excel file, even if merged in the manuscript.
Figures and photographs
Photographs, X-rays, CT scans, MRI and photo micro-graphs should be sent in digital format with a minimum resolution of 3.2 mega pixels in JPEG compression. Photographs must be sharply focused. Most photographs taken with a mobile phone camera do not fulfill the necessary requirements and, therefore, not acceptable for printing. The photographs submitted must be those originally taken as such by a camera without manipulating them digitally. Photographs of published articles will not be returned. If photographs of patients are used, either they should not be identifiable or the photographs should be accompanied by written permission to use them.
System International (S.I) Unit measurement should be used. Imperial measurement units like inches, feet etc. are not acceptable.
Authors should identify that informed consent was obtained when applicable. The manuscript should also include the notation that the study was approved by the institutional committee on human research. Photographs of identifiable persons must be accompanied by signed releases showing informed consent. When reporting experiments on human subjects, it should be clearly indicated whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 1983. Patient’s names, initials or hospital numbers, especially in illustrative material should not be used. When reporting experiments on animals, indicate whether the institution’s or a national research council’s guidelines for or any national law on, the care and use of laboratory animals were followed. All clinical research papers must be accompanied by evidence of peer review. The date the project was approved, when available, should also be included.
All manuscripts national and international are processed free of charge.
Policy on Plagiarism
Plagiarism is the unethical act of copying someone else’s prior ideas, processes, results or words without explicit acknowledgement of the original author and source. Self-plagiarism occurs when an author utilizes large part of his/her own previously published work without using appropriate references. This can range from getting the same manuscript published in multiple journals to modifying a previously published manuscript with some new data. The journal is strictly against any unethical act of copying or plagiarism in any form. Plagiarism is said to have occurred when large portions of a manuscript have been copied from existing previously published resources. All manuscripts submitted for publication to LMRJ are cross-checked for plagiarism using Turnitin Software. Manuscripts found to be plagiarized during initial stages of review are out-rightly rejected and not considered for publication in the journal.
Clinical Trial Number
For publishing a Clinical Trial in LMRJ, the TRIAL NUMBER provided by the Drug Regulatory Authority of Pakistan (DRAP) is mandatory by law. The Trial may involve Drugs or Appliances.
"DRAP is an autonomous body under the administrative control of the Federal Government with its headquarters at Islamabad. DRAP is an Authority that provides approval to conduct clinical trials and import drugs which are to be used in clinical trials".
For more details access the following websites:
Checklist for the Author (S)
- Cover Letter
- Ethical statement for Research (only exception are letters to the editor and review articles; case reports require approval from the head of the department)
- Complete Submission Statement Form signed by hand by all authors
- Details of all authors including full names, email addresses, phone numbers and affiliations and degrees/year of study
- Sequence of the headings should be adhered to strictly. Formatting of points 3-8 will depend on each manuscript type.
- MeSH Words
- Conflict of Interest
- Funding disclosure
- References. Should be listed in Vancouver format in ascending order
- Tables. Should be labelled and inserted in ascending order. These should appear at the end of the text and not inserted between the article sections
- Figures. Should be appropriately labelled with numbers and appear with legends. All figures should be uploaded separately on the eJManager/webpage (online submission).
- Additional supplemental files and documents as required.
Use of the Digital Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI is a unique alpha-numeric character string assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes and is therefore an ideal medium for citing documents, particularly articles in press because they have not yet received their full bibliographic information. Here is an example of a correctly given
Here you will find everything from Frequently Asked Questions to ways to get in touch.
You can also check the status of your submitted article or find out when your accepted article will be published.
Copyright to all articles and supplementary tables, illustrations, or other information published in Liaquat Medical Research Journal will be held by author. Copyright forms are completed and submitted online according to instructions sent at the time of acceptance. The corresponding author will be asked to sign on behalf of all co-authors of the manuscript and is responsible for sharing the terms of the copyright transfer with his co-authors.
The Journal provides Gold Open Access, copyright lies with authors and protected under CC BY-NC-ND 4.0 licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
Liaquat Medical Research Journal is part of the medical university and follows a strict policy approved by university that we do not advertise for any product or company in our journal in any form either print/online.
Allegations of Research Misconduct Policy
Journal of Liaquat University of Medical & Health Sciences policy for managing allegations of research misconduct is based on the guidelines of the Committee on Publication Ethics (COPE), available at https://publicationethics.org/misconduct.
Authors are required to read the journal’s author instruction and ethical policies carefully and to adhere to the terms before submission. While authors are given the option to suggest potential reviewers for the peer-review process, the qualifications and potential conflicts of interest of all reviewers will be carefully checked before they are invited to review.
Report of research misconduct may be related to a published article or a manuscript under peer review process. The procedure for the application and management of complaints of author misconduct should proceed with sensitivity, tact, in confidence, and in the following manner:
- The editorial office of the journal receives a complaint that an article submitted to or published in the journal is suspected of containing research misconduct.
- The complainant needs to clearly indicate the specific manner and detail of misconduct; for example, in a case of plagiarism, the plagiarized paragraph should be clearly highlighted and the original and suspected articles should be referred to clearly.
- The editorial office will conduct an investigation, during which time the editor of the journal and the corresponding author(s) of the suspected article will be in contact.
- The corresponding author(s) will be asked to provide an explanation with factual statements and any available evidence.
- If the author(s) of the suspected article accepts the misconduct complaint, the editorial office will take the following actions depending on the situation:
- If the article has been published, an erratum or retraction may be necessary to remedy the situation. However, there may still be disagreement concerning the appropriate wording of the description.
- If the misconduct is reported during the review process, the review process may continue, with the author(s) making the relevant changes.
- In the case of nonresponse in the stipulated time or an unsatisfactory explanation, the article may be permanently retracted or rejected. Before making a decision, confirmation will be sought from the experts of the relevant institution or other authorities as required.
- The complainant will be informed of the outcome once the issue is resolved.
- The complaint case will there upon be considered concluded.
Statement of Conflict of Interest:
Public trust in the peer review process and the credibility of published articles depend in part on how well conflict of interest is handled during writing, peer review, and editorial decision making. Conflict of interest exists when an author (or the author's institution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from those with negligible potential to those with great potential to influence judgment, and not all relationships represent true conflict of interest. The potential for conflict of interest can exist whether or not an individual believes that the relationship affects his or her scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself. However, conflicts can occur for other reasons, such as personal relationships, academic competition, and intellectual passion.
- International Committee of Medical Journal Editors ("Uniform Requirements for Manuscripts Submitted to Biomedical Journals") -- February 2006
Authors of manuscripts submitted to LMRJ must inform about funding sources for the research they intend to publish.
The Process for Handling Cases Requiring Corrections, Retractions, and Editorial
Expressions of Concern
Journal of Liaquat University of Medical & Health sciences and its editorial team ensures that all authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals by the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org/icmje-recommendations.pdf) and the guidelines of the Committee on Publication Ethics (COPE) (https://publicationethics.org/guidance). We aim to ensure the integrity of the academic record of all published or potential publications. Whenever it is recognized that a significant inaccuracy, misleading statement, or distorted report has been published, it must be corrected promptly and with due prominence. If, after an appropriate investigation, an item proves to be fraudulent, it should be retracted. The retraction should be clearly identifiable to readers and indexing systems.
Errors in published papers may be identified in the form of a corrigendum or erratum when the Editor-in-Chief considers it appropriate to inform the journal readership about a previous error and makes a correction to the error in the published article. The corrigendum or erratum will appear as a new article in the journal, and will cite the original published article.
Retractions are considered and published when there are severe errors in an article that invalidate the conclusions. Retractions are also made in cases where there is evidence of publication malpractice, such as plagiarism, duplicate publication, or unethical research. According to industry best practice and in accordance with COPE guidelines, LMRJ implements the following procedure if a retraction is confirmed:
- A retraction note titled “Retraction: [article title]” signed by the authors and/or the editor is published in a subsequent issue of the journal and listed in the contents list.
- In the electronic version, a link is made to the original article.
- The online article is preceded by a screen containing the retraction note. It is to this screen that the link resolves; the reader can then proceed to the article itself.
- The original article is retained unchanged save for a watermark on the PDF indicating on each page that it has been “retracted.”
Editorial expressions of concern
Where substantial doubt arises as to the honesty or integrity of a submitted or published article, journal editors may consider issuing an expression of concern. However, expressions of concern should only be issued if an investigation into the problems relating to the article has proven inconclusive, and if there remain strong indicators that the concerns are valid. Under some rare cases, an editorial expression of concern may also be issued when an investigation is underway but a judgment will not be available for a considerable time. The expression of concern will be linked back to the published article it relates to.
Data sharing Policy
Scientific results are only as strong as they are reproducible, so being able to identify and use research data is vital to building knowledge. To help make all scientific data more transparent, we encourage the authors to state the availability of their data. With the data statement, authors can be transparent about the data they used in an article and make a statement about its availability together with their published article.
Data Statement at a Glance
With data statement, an author can provide information about the data presented in an article and provide a reason if data is not available to access. The data statement will appear under the "research data" section from the article outline.
Benefits for authors and readers:
- Increases transparency
- Allows compliance with data policies.
- Encourages good scientific practice and encourages trust
Why should I share my research data?
There are so many good reasons. Find out more and discover how you can share research data.
Example: Research data for this article
Due to the sensitive nature of the questions asked in this study, survey respondents were assured raw data would remain confidential and would not be shared.
Data not available / The data that has been used is confidential
All the data which is mentioned and support the findings in the articles published in LMRJ are available on request from the corresponding author.
The data is not publicly available due to privacy or ethical restrictions.
Articles are accepted for publication on the condition that they are contributed solely to LMRJ. As per HEC policy all manuscripts will be submitted through our Open Journal System website by registering and logging into the account along with all the required documents. One hard copy of all the manuscripts along with all the required documents should be submitted for publication at our office.
All articles are reviewed by two referees with double blind peer review process. Acceptance is based on significance, originality, and validity of the material. If the article is accepted for publication, editorial revisions may be made to aid clarity and understanding without altering the meaning.
Statements and opinions expressed in the articles and communications herein are those of the author(s) and not necessarily those of the Editor(s) or publisher, and the Editor(s) and publisher disclaim any responsibility or liability for such material. Neither the Editor(s) nor the publisher guarantees, warrants, or endorses any product or service mentioned in this publication; neither do they guarantee any claim made by the manufacturer of such product or service. In accordance with the Copyright Act, the following statement signed by all authors must accompany each manuscript submitted for publication: “The undersigned author(s) transfer all copyright ownership of the manuscript to the Journal of Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan in the event the work is published. The undersigned warrant(s) that the article is original, does not infringe upon any copyright or other proprietary right of any third party, is not under consideration by another journal, and has not been published previously”.
Statement of Informed consent:
Authors should identify that informed consent was obtained when applicable.
Peer review process
LMRJ has two stage review system: as soon as an article is submitted it passes through plagiarism software by the editorial team, followed by editorial review for the quality and suitability of the content of the submitted article. Editorial board members submit their comments on a structured Editorial review form. If the manuscript is approved at the editorial review then it undergoes “DOUBLE BLIND PEER REVIEW” process by 2 subject specialists. The suggestions and objections of the reviewers after blinding are communicated to authors and only when the reviewers are satisfied with the response of the authors only then the manuscripts are accepted for publication. The reviewers of the manuscripts should not be from the same institute, neither the members of Editorial or Advisory board can act as the reviewers even if they have expertise in the subject.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
Open access policy
The articles published immediately made Open access without any embargo policy.
Open access journal copyright lies with authors and protected under CC BY-NC-ND 4.0 licence (https://creativecommons.org/licenses/by-nc-nd/4.0/). Authors are free to share their work to any source of their interest without any restriction
Copyright to all articles and supplementary tables, illustrations, or other information published in Liaquat Medical Research Journal will be held by author. The work published in LMRJ can be shared without any restriction to any forum, however once its published it can not be changed.
Open access journal copyright lies with authors and protected under CC BY-NC-ND 4.0 licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Copyright will be mentioned in each published article on journal webpage.
LMRJ has Zero tolerance for plagiarism. Similarity index of each submitted manuscript is checked and verified by the editorial board members as soon as it is submitted, then before sending it to the publication process after review. At any stage it should be <19% with no single source similarity of 5%.
For a clear concept Plagiarism is an unethical act of copying someone else’s prior ideas, processes, results or words without explicit acknowledgement of the original author and source. Self-plagiarism occurs when an author utilizes large part of his/her own previously published work without using appropriate references. This can range from getting the same manuscript published in multiple journals to modifying a previously published manuscript with some new data.
LMRJ is strictly against any unethical act of copying or plagiarizing in any form. Manuscripts found to be plagiarized at any stage of review and publication are out-rightly rejected and not considered for publication in the journal.
From 30th June 2023 a publication fees of PKR 20,000/= will be charged for accepted original articles for national authors for International authors there will be a publication fees of USD 100. There will no fees for publication of invited articles, review articles and case reports.